U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula Hg.O4S
Molecular Weight 296.65
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MERCURIC SULFATE

SMILES

[Hg++].[O-]S([O-])(=O)=O

InChI

InChIKey=DOBUSJIVSSJEDA-UHFFFAOYSA-L
InChI=1S/Hg.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2

HIDE SMILES / InChI
Molecular Formula O4S
Molecular Weight 96.063
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula Hg
Molecular Weight 200.59
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

SULFATE (as sodium sulfate, potassium sulfate, and magnesium sulfate) is a component of SUPREP Bowel Prep Kit. It is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults. Sulfate salts provide sulfate anions, which are poorly absorbed. The osmotic effect of unabsorbed sulfate anions and the associated cations causes water to be retained within the gastrointestinal tract. SUPREP Bowel Prep Kit, when ingested with a large volume of water, produces copious watery diarrhea.

Approval Year

1921
1467
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Approved
8429
SUPREP Bowel Prep Kit

Approved Use

SUPREP Bowel Prep Kit is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults.

Launch Date

2010
PubMed

PubMed

TitleDatePubMed
Heparan sulphate in the binding and activation of basic fibroblast growth factor.
1992 Dec
Death by tanning--a case of fatal basic chromium sulphate poisoning.
1994
Heparan sulphate. Regulation of growth factors in the mammary gland.
2000
Magnesium sulphate for preventing preterm birth in threatened preterm labour.
2002
[Skin patch test with nickel sulphate--an attempt of broader interpretation of the results].
2002 Aug
Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.
2003
Intravenous magnesium sulphate in acute myocardial infarction--is the answer "MAGIC"?
2003 Mar
Are low dehydroepiandrosterone sulphate levels predictive for cardiovascular diseases? A review of prospective and retrospective studies.
2003 Oct
Characterization of the Herpesvirus saimiri Orf51 protein.
2004 Aug 15
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
2004 Jan
Chondroitin sulphate: antioxidant properties and beneficial effects.
2006 Dec
Heparin/heparan sulphate binding in the TGF-beta cytokine superfamily.
2006 Jun
Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors.
2006 Jun
Overcoming chondroitin sulphate proteoglycan inhibition of axon growth in the injured brain: lessons from chondroitinase ABC.
2007
Patents

Patents

03931143
17
03931217
10
03931218
7
03931239
39
03931412
37
03932479
112
03932483
74
03932505
8
03932630
7
03939185
7
03940407
8
03940411
9
03943151
7
03943154
9
03946008
8
03947582
12
03966830
12
03983253
7
03992189
8
04001300
7
04013695
7
04016182
7
04028419
7
04036979
10
04049659
8
04052511
8
04055602
7
04061771
12
04066543
7
04073798
8
04078006
9
04086278
7
04086338
8
04105776
10
04124601
7
04128653
7
04154840
19
04154937
7
04156670
8
04160657
7
04164543
14
04171447
7
04190433
7
04191830
8
04205178
7
04229207
7
04242265
8
04273704
7
04278808
7
04324729
7
04337197
7
04340415
7
04340747
7
04342737
7
04350633
9
04351846
7
04355105
7
04395414
8
04396772
7
04401808
8
04453013
8
04454291
7
04454292
7
04461896
16
04477369
7
04533660
37
04536402
7
04549019
10
04565882
8
04611002
7
04613463
35
04621078
7
04657700
7
04690936
10
04692458
8
04711895
8
04734420
73
04736057
8
04745124
8
04751018
8
04760161
8
04764512
7
04778790
7
04788010
7
04831153
7
04889859
9
04894458
12
04931568
7
04954278
7
04954328
8
05112863
7
05232624
7
05401621
7
06071927
10
06110491
7
06528526
7
07932007
7
07932354
7

Sample Use Guides

In Vivo Use Guide
Split-Dose (2-Day) Regimen: The evening before colonoscopy: dilute one bottle with water to a total volume of 16 oz. (up to the fill line) and drink the entire amount. Drink 32 ounces of water over the next hour. Next morning: repeat both steps using the second bottle. Complete preparation at least 2 hours before colonoscopy or as directed by a physician.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:10:24 GMT 2023
Edited
by admin
on Fri Dec 15 17:10:24 GMT 2023
Record UNII
J4L3PPG58I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MERCURIC SULFATE
HSDB   MI   WHO-DD  
Common Name English
MERCURY(II) SULFATE
Systematic Name English
MERCURY(II) SULFATE (1:1)
Systematic Name English
MERCURIC SULFATE [MI]
Common Name English
Mercuric sulfate [WHO-DD]
Common Name English
MERCURY SULPHATE (HGSO4)
Common Name English
MERCURIUS SULPHURICUS [HPUS]
Common Name English
SULFURIC ACID, MERCURY(2+) SALT (1:1)
Common Name English
MERCURY(II) SULPHATE
Systematic Name English
MERCURIC SULFATE [HSDB]
Common Name English
MERCURY(II) SULPHATE (1:1)
Systematic Name English
MERCURIUS SULPHURICUS
HPUS  
Common Name English
MERCURIC SULPHATE
Common Name English
MERCURY SULFATE (HGSO4)
Common Name English
Code System Code Type Description
WIKIPEDIA
MERCURY(II) SULFATE
Created by admin on Fri Dec 15 17:10:25 GMT 2023 , Edited by admin on Fri Dec 15 17:10:25 GMT 2023
PRIMARY
SMS_ID
100000125913
Created by admin on Fri Dec 15 17:10:25 GMT 2023 , Edited by admin on Fri Dec 15 17:10:25 GMT 2023
PRIMARY
DAILYMED
J4L3PPG58I
Created by admin on Fri Dec 15 17:10:25 GMT 2023 , Edited by admin on Fri Dec 15 17:10:25 GMT 2023
PRIMARY
FDA UNII
J4L3PPG58I
Created by admin on Fri Dec 15 17:10:25 GMT 2023 , Edited by admin on Fri Dec 15 17:10:25 GMT 2023
PRIMARY
MERCK INDEX
m7225
Created by admin on Fri Dec 15 17:10:25 GMT 2023 , Edited by admin on Fri Dec 15 17:10:25 GMT 2023
PRIMARY Merck Index
CAS
7783-35-9
Created by admin on Fri Dec 15 17:10:25 GMT 2023 , Edited by admin on Fri Dec 15 17:10:25 GMT 2023
PRIMARY
MESH
C028430
Created by admin on Fri Dec 15 17:10:25 GMT 2023 , Edited by admin on Fri Dec 15 17:10:25 GMT 2023
PRIMARY
EPA CompTox
DTXSID7064819
Created by admin on Fri Dec 15 17:10:25 GMT 2023 , Edited by admin on Fri Dec 15 17:10:25 GMT 2023
PRIMARY
HSDB
1247
Created by admin on Fri Dec 15 17:10:25 GMT 2023 , Edited by admin on Fri Dec 15 17:10:25 GMT 2023
PRIMARY
PUBCHEM
24544
Created by admin on Fri Dec 15 17:10:25 GMT 2023 , Edited by admin on Fri Dec 15 17:10:25 GMT 2023
PRIMARY
RXCUI
1311475
Created by admin on Fri Dec 15 17:10:25 GMT 2023 , Edited by admin on Fri Dec 15 17:10:25 GMT 2023
PRIMARY RxNorm
ECHA (EC/EINECS)
231-992-5
Created by admin on Fri Dec 15 17:10:25 GMT 2023 , Edited by admin on Fri Dec 15 17:10:25 GMT 2023
PRIMARY
EVMPD
SUB32965
Created by admin on Fri Dec 15 17:10:25 GMT 2023 , Edited by admin on Fri Dec 15 17:10:25 GMT 2023
PRIMARY
Related Record Type Details
Structure of SULFATE ION
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966